NewAmsterdam Pharma Company NV (NAMS) is destined for greater heights as its last quarter sales were 12,770 K
On Tuesday, NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was -6.13% drop from the session before settling in for the closing price of $20.24. A 52-week